ImmuCell Corporation
Organization details
- Legal name
- ImmuCell Corporation
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2835 — In Vitro & In Vivo Diagnostic Substances
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Portland
- Headquarters state / province
- Maine
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ICCC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000811641
- EIN
- 01-0382980
Board of directors
-
Anthony DiMarco · DirectorSince 2026
-
Bobbi Jo Brockmann · Director · VP of Sales and MarketingSince 2026
-
Boekhorst Paul Francis Olivier Te · Director · President and CEOSince 2025
-
Bryan K. Gathagan · DirectorSince 2023
-
David Cunningham · DirectorSince 2023
-
David Scott Tomsche · DirectorSince 2023
-
Gilles Guillemette · DirectorSince 2026
-
Gloria F. Basse · DirectorSince 2020
-
Kathy Turner V · DirectorSince 2026
-
Michael F. Brigham · DirectorSince 2026
-
Paul R. Wainman · DirectorSince 2023
-
Steven T. Rosgen · DirectorSince 2023
-
Timothy C. Fiori · Director · Chief Financial OfficerSince 2026
Chief executives
Mixed · grade D
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 59
4.3% a year in revenue
20% of the scoring weight is on file. Figures cover December 2024 – December 2025.
Director election results
Annual meeting of June 11, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
99.6%
-
99.6%
-
99.7%
-
99.8%
-
99.8%
-
99.8%
Board connections
1 of this board's directors also sit on 1 other board. 1 is in the same sector.
-
Elanco Animal Health Incorporated Same sectorvia Kathy Turner V
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $140,146
- 6 purchases by 2 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 2026 | Boekhorst Paul Francis Olivier Te Director, Officer (President and CEO) | Open-market purchase | +8,000 | $9.50 | $76,000 |
| Mar 20, 2026 | Michael F. Brigham Director | Option exercise | +25,000 | $5.84 | $146,000 |
| Mar 20, 2026 | Michael F. Brigham Director | Shares withheld for tax | −24,052 | $6.07 | $145,996 |
| Dec 3, 2025 | Boekhorst Paul Francis Olivier Te Director, Officer (President and CEO) | Open-market purchase | +2,556 | $5.00 | $12,780 |
| Dec 3, 2025 | Boekhorst Paul Francis Olivier Te Director, Officer (President and CEO) | Open-market purchase | +3,521 | $5.04 | $17,746 |
| Dec 2, 2025 | Boekhorst Paul Francis Olivier Te Director, Officer (President and CEO) | Open-market purchase | +3,708 | $4.87 | $18,058 |
| Nov 25, 2025 | David Scott Tomsche Director | Open-market purchase | +1,633 | $4.76 | $7,773 |
| Nov 25, 2025 | David Scott Tomsche Director | Open-market purchase | +1,633 | $4.77 | $7,789 |
| Jun 12, 2025 | Bryan K. Gathagan Director | Open-market purchase | +1,000 | $6.32 | $6,320 |
| Jun 11, 2025 | Gloria F. Basse Director | Option exercise | +3,530 | $4.81 | $16,979 |
| Aug 28, 2024 | David Scott Tomsche Director | Sold back to the company | +2,186 | $3.55 | $7,760 |
| Aug 23, 2024 | David Scott Tomsche Director | Sold back to the company | +6,005 | $3.55 | $21,318 |
| Aug 22, 2024 | David Scott Tomsche Director | Sold back to the company | +10,000 | $3.55 | $35,500 |
| Aug 19, 2024 | David Scott Tomsche Director | Sold back to the company | +3,172 | $3.67 | $11,641 |
| Aug 16, 2024 | David Scott Tomsche Director | Sold back to the company | +4,811 | $3.72 | $17,897 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about ImmuCell Corporation
Who is the CEO of ImmuCell Corporation?
Boekhorst Paul Francis Olivier Te has been ImmuCell Corporation's President and CEO since October 2025.
How many directors are on ImmuCell Corporation's board?
ImmuCell Corporation's board has 13 directors: Anthony DiMarco, Bobbi Jo Brockmann, Boekhorst Paul Francis Olivier Te, Bryan K. Gathagan, David Cunningham, David Scott Tomsche, Gilles Guillemette, Gloria F. Basse, Kathy Turner V, Michael F. Brigham and 3 others.
Are ImmuCell Corporation insiders buying or selling shares?
Over the last 12 months, ImmuCell Corporation insiders bought $140,146 of shares in 6 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="immucell-corporation"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.